$120.79
+0.18 (+0.15%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
-40.7% upside
Low Target
$49.68
Average Target
$71.60
High Target
$88.34
Current Price
$120.79
Current
$120.79
$120.79
Target
$71.60
$71.60
$49.68
$71.60 avg
$88.34
Scenario Analysis
Bear Case
$49.68
-58.9%
Low target
Base Case
$71.60
-40.7%
Avg target
Bull Case
$88.34
+-26.9%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$219.71
-45.0% from high
52-Week Low
$23.30
+418.4% from low
50-Day SMA
$151.35
-20.2% vs SMA
200-Day SMA
$91.22
+32.4% vs SMA
RSI (14)
43.3
Neutral
Target vs 52W High
$71.60
-67.4% vs high
Next Earnings Report
Nov 12, 2026 · Before Market Open
4d
until earnings
EPS Est: $-0.38
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |